SlideShare uma empresa Scribd logo
1 de 33
Baixar para ler offline
Molecular Design: One step back and two paths forward
Peter W Kenny (pwk.pub.2008@gmail.com)
Some things that are hurting Pharma
• Having to exploit targets that are less well-linked to
human disease
• Inability to predict idiosyncratic toxicity
• Inability to measure free (unbound) physiological
concentrations of drug for remote targets (e.g.
intracellular or within blood brain barrier)
Dans la merde: http://fbdd-lit.blogspot.com/2011/09/dans-la-merde.html
Keep an eye out for creative data analysis
Add Normally-distributed noise
Data set A Data set B
Points plotted at
constant increment
Equal numbers of points
for each value of x
Preparation of data sets
r2 = 0.99
RMSE = 0.36
Data set A: Fit median value of Y to X
An example of this approach to plotting data can be seen in Leeson & Springthorpe, The influence of
drug-like concepts on decision-making in medicinal chemistry. Nat. Rev. Drug Discov. 2007, 7, 881-890.
Low Medium High
Data set B: Use value of X to split into three equally-sized groups
and show mean and associated confidence interval for each
An example of this approach to analysing data can be seen in: Gleeson, Generation of a
Set of Simple, Interpretable ADMET Rules of Thumb. J. Med. Chem. 2008, 51, 817-834.
What data set A really looks like
Fit to original data
N=11000; r2 = 0.09 ; RMSE = 9.95
Fit to transformed data
N=11; r2 = 0.99 ; RMSE = 0.36
Percentile plot (see Colclough et al
BMC 2008, 16, 6611-6616)
90%
75%
50%
25%
10%
Residual plot for fit to original data
Fit to original data
N=10000; r2 = 0.08 ; RMSE = 10.0)
Residual plot for fit to original data
Low Medium High
What data set B really looks like
Mean values of Y and (barely visible)
confidence intervals shown with
standard deviations
x
Octanol was the first mistake...
Lipophilic & half ionised Hydrophilic
Introduction to partition coefficients
Polarity
N
ClogP ≤ 5 Acc ≤ 10; Don ≤5
An alternative view of the Rule of 5
Does octanol/water ‘see’ hydrogen bond donors?
--0.06 -0.23 -0.24
--1.01 -0.66
Sangster lab database of octanol/water partition coefficients: http://logkow.cisti.nrc.ca/logkow/index.jsp
--1.05
Octanol/Water Alkane/Water
Octanol/water is not the only partitioning system
logPoct = 2.1
logPalk = 1.9
DlogP = 0.2
logPoct = 1.5
logPalk = -0.8
DlogP = 2.3
logPoct = 2.5
logPalk = -1.8
DlogP = 4.3
Differences in octanol/water and alkane/water logP values
reflect hydrogen bonding between solute and octanol
Toulmin et al, J. Med. Chem. 2008, 51, 3720-3730
DlogP = 0.5
PSA/ Å2 = 48
Polar Surface Area is not predictive of
hydrogen bond strength
Toulmin et al, J. Med. Chem. 2008, 51, 3720-3730
DlogP = 4.3
PSA/ Å2 = 22
1.0 1.1 0.8 1.3 1.7
0.8 1.5
Measured values of DlogP
Toulmin et al, J. Med. Chem. 2008, 51, 3720-3730
1.6 1.1
DlogP
(corrected)
Vmin/(Hartree/electron)
DlogP
(corrected)
Vmin/(Hartree/electron)
N or ether O
Carbonyl O
Prediction of contribution of acceptors to DlogP
Toulmin et al, J. Med. Chem. 2008, 51, 3720-3730
DlogP = DlogP0 x exp(-kVmin)
logPoct = 0.89
predicted logPalk = -4.2
PSA/Å2 = 53
logPoct = 1.58
predicted logPalk = -1.4
PSA/Å2 = 65
Lipophilicity/polarity of Morphine & Heroin
Toulmin et al, J. Med. Chem. 2008, 51, 3720-3730
logPhxdlogPoct
log(Cbrain/Cblood)
DlogP
Prediction of blood/brain partitioning
R2 = 0.66
RMSE = 0.54
R2 = 0.82
RMSE = 0.39
R2 = 0.88
RMSE = 0.32
Toulmin et al, J. Med. Chem. 2008, 51, 3720-3730
Difficulties in measuring logPalk:
Many compounds poorly soluble in alkanes
Self-association masks polarity
Alkane/water partition coefficients: Where next?
General access to logPalk
likely to require predictive
models for some time
Carefully measure logPalk
for structurally diverse
compounds
Solvation models: logPalk
easier to measure than
ΔG(gaq)
Another way to look at SAR
(Descriptor-based) QSAR/QSPR:
Some questions
• How valid is methodology (especially for validation)
when distribution of compounds in training/test space
is highly non-uniform?
• Are models predicting activity or locating neighbours?
• Are ‘global’ models ensembles of local models?
• How well do the methods handle ‘activity cliffs’?
• How should we account for sizes of descriptor pools
when comparing models?
Measures of Diversity & Coverage
•
• •
•
•
•
•
•
•
•
•
•
•
•
•
2-Dimensional representation of chemical space is used here to illustrate concepts of diversity
and coverage. Stars indicate compounds selected to sample this region of chemical space.
In this representation, similar compounds are close together
Neighborhoods and library design
Examples of relationships between structures
Tanimoto coefficient (foyfi) for structures is 0.90
Ester is methyl-substituted acid Amides are ‘reversed’
Leatherface molecular editor
From chain saw to Matched Molecular Pairs
c-[A;!R]
bnd 1 2
c-Br
cul 2
hyd 1 1
[nX2]1c([OH])cccc1
hyd 1 1
hyd 3 -1
bnd 2 3 2
Kenny & Sadowski Structure modification in chemical databases, Methods and Principles in Medicinal
Chemistry (Chemoinformatics in Drug Discovery 2005, 23, 271-285.
Glycogen Phosphorylase inhibitors:
Series comparison
DpIC50
DlogFu
DlogS
0.38 (0.06)
-0.30 (0.06)
-0.29 (0.13)
DpIC50
DlogFu
DlogS
0.21 (0.06)
0.13 (0.04)
0.20 (0.09)
DpIC50
DlogFu
DlogS
0.29 (0.07)
-0.42 (0.08)
-0.62 (0.13)
Standard errors in mean values shown in parenthesis; see Birch et al, BMCL 2009, 19, 850-853
Effect of bioisosteric replacement
on plasma protein binding
?
Date of Analysis N DlogFu SE SD %increase
2003 7 -0.64 0.09 0.23 0
2008 12 -0.60 0.06 0.20 0
Mining PPB database for carboxylate/tetrazole pairs suggested that bioisosteric
replacement would lead to decrease in Fu so tetrazoles not synthesised.
Birch et al, BMCL 2009, 19, 850-853
Amide N DlogS SE SD %Increase
Acyclic (aliphatic amine) 109 0.59 0.07 0.71 76
Cyclic 9 0.18 0.15 0.47 44
Benzanilides 9 1.49 0.25 0.76 100
Effect of amide N-methylation on aqueous solubility
is dependent on substructural context
Birch et al, BMCL 2009, 19, 850-853
Relationships between structures
Discover new
bioisosteres
Prediction of activity
& properties
Recognise
extreme data
Direct prediction
(e.g. look up
substituent effects)
Indirect prediction
(e.g. apply correction
to existing model)
Bad measurement
or interesting effect?
Conclusions
• Data can be massaged and correlations can
be enhanced but it won’t extract us from ‘la
merde’
• There is life beyond octanol/water if we
choose to look for it
• Even molecules can have meaningful
relationships
Selected references
• Seiler (1974) Interconversion of lipophilicities from hydrocarbon/water systems into the octanol/water
system. Eur. J. Med. Chem. 9, 473–479.
• Toulmin, Wood & Kenny (2008) Toward Prediction of Alkane/Water Partition Coefficients. J. Med. Chem.
51, 3720-3730. http://dx.doi.org/10.1021/jm701549s
• Kenny & Sadowskii (2005) Structure modification in chemical databases. Methods and Principles in
Medicinal Chemistry 23(Chemoinformatics in Drug Discovery), 271-285
http://dx.doi.org/10.1002/3527603743.ch11
• Leach et al (2006) Matched Molecular Pairs as a Guide in the Optimization of Pharmaceutical Properties; a
Study of Aqueous Solubility, Plasma Protein Binding and Oral Exposure,. J. Med. Chem. 49, 6672-6682.
http://dx.doi.org/10.1021/jm0605233
• Birch et al (2009) Matched molecular pair analysis of activity and properties of glycogen phosphorylase
inhibitors. Bioorg. Med. Chem. Lett. 19, 850-853. http://dx.doi.org/10.1016/j.bmcl.2008.12.003
• Wassermann, Wawer & Bajorath (2010) Activity Landscape Representations for Structure−Activity
Relationship Analysis. J. Med. Chem. 53, 8209-8223. http://dx.doi.org/10.1021/jm100933w
Alkane/water partition coefficents
Relationships between structures

Mais conteúdo relacionado

Mais procurados

Reactive Chemical Hazard Alerting in Pharmaceutical Notebooks
Reactive Chemical Hazard Alerting in Pharmaceutical NotebooksReactive Chemical Hazard Alerting in Pharmaceutical Notebooks
Reactive Chemical Hazard Alerting in Pharmaceutical NotebooksNextMove Software
 
Studying Reversible Self-Association of Biopharmaceuticals using AUC and Ligh...
Studying Reversible Self-Association of Biopharmaceuticals using AUC and Ligh...Studying Reversible Self-Association of Biopharmaceuticals using AUC and Ligh...
Studying Reversible Self-Association of Biopharmaceuticals using AUC and Ligh...KBI Biopharma
 
Analyzing Aggregates of Different Sizes and Types: SEC vs. Analytical Ultrace...
Analyzing Aggregates of Different Sizes and Types: SEC vs. Analytical Ultrace...Analyzing Aggregates of Different Sizes and Types: SEC vs. Analytical Ultrace...
Analyzing Aggregates of Different Sizes and Types: SEC vs. Analytical Ultrace...KBI Biopharma
 
Structure based and ligand based drug designing
Structure based and ligand based drug designingStructure based and ligand based drug designing
Structure based and ligand based drug designingDr Vysakh Mohan M
 
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...KBI Biopharma
 
Fragment screening library workshop (IQPC 2008)
Fragment screening library workshop (IQPC 2008)Fragment screening library workshop (IQPC 2008)
Fragment screening library workshop (IQPC 2008)Peter Kenny
 
From screening to molecular interactions: A short tour
From screening to molecular interactions: A short tour From screening to molecular interactions: A short tour
From screening to molecular interactions: A short tour Peter Kenny
 
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...KBI Biopharma
 
New Approaches to Investigating the Self-Association and Colloidal Stability ...
New Approaches to Investigating the Self-Association and Colloidal Stability ...New Approaches to Investigating the Self-Association and Colloidal Stability ...
New Approaches to Investigating the Self-Association and Colloidal Stability ...KBI Biopharma
 
Measuring Comparability of Conformation, Heterogeneity and Aggregation with C...
Measuring Comparability of Conformation, Heterogeneity and Aggregation with C...Measuring Comparability of Conformation, Heterogeneity and Aggregation with C...
Measuring Comparability of Conformation, Heterogeneity and Aggregation with C...KBI Biopharma
 
Standardized Representations of ELN Reactions for Categorization and Duplicat...
Standardized Representations of ELN Reactions for Categorization and Duplicat...Standardized Representations of ELN Reactions for Categorization and Duplicat...
Standardized Representations of ELN Reactions for Categorization and Duplicat...NextMove Software
 
2015_July GC Synergy from E.coli to Cancer V3
2015_July GC Synergy from E.coli to Cancer V32015_July GC Synergy from E.coli to Cancer V3
2015_July GC Synergy from E.coli to Cancer V3Ronald Lambert
 
Improving enrichment rates
Improving enrichment ratesImproving enrichment rates
Improving enrichment ratesbaoilleach
 
Reaxys Medicinal Chemistry 2014
Reaxys Medicinal Chemistry 2014Reaxys Medicinal Chemistry 2014
Reaxys Medicinal Chemistry 2014Reaxys
 
Analyzing Aggregates by Sedimentation Velocity and Light Scattering
Analyzing Aggregates by Sedimentation Velocity and Light ScatteringAnalyzing Aggregates by Sedimentation Velocity and Light Scattering
Analyzing Aggregates by Sedimentation Velocity and Light ScatteringKBI Biopharma
 

Mais procurados (17)

Reactive Chemical Hazard Alerting in Pharmaceutical Notebooks
Reactive Chemical Hazard Alerting in Pharmaceutical NotebooksReactive Chemical Hazard Alerting in Pharmaceutical Notebooks
Reactive Chemical Hazard Alerting in Pharmaceutical Notebooks
 
Studying Reversible Self-Association of Biopharmaceuticals using AUC and Ligh...
Studying Reversible Self-Association of Biopharmaceuticals using AUC and Ligh...Studying Reversible Self-Association of Biopharmaceuticals using AUC and Ligh...
Studying Reversible Self-Association of Biopharmaceuticals using AUC and Ligh...
 
Analyzing Aggregates of Different Sizes and Types: SEC vs. Analytical Ultrace...
Analyzing Aggregates of Different Sizes and Types: SEC vs. Analytical Ultrace...Analyzing Aggregates of Different Sizes and Types: SEC vs. Analytical Ultrace...
Analyzing Aggregates of Different Sizes and Types: SEC vs. Analytical Ultrace...
 
Structure based and ligand based drug designing
Structure based and ligand based drug designingStructure based and ligand based drug designing
Structure based and ligand based drug designing
 
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
 
Fragment screening library workshop (IQPC 2008)
Fragment screening library workshop (IQPC 2008)Fragment screening library workshop (IQPC 2008)
Fragment screening library workshop (IQPC 2008)
 
From screening to molecular interactions: A short tour
From screening to molecular interactions: A short tour From screening to molecular interactions: A short tour
From screening to molecular interactions: A short tour
 
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
 
Drug design
Drug designDrug design
Drug design
 
New Approaches to Investigating the Self-Association and Colloidal Stability ...
New Approaches to Investigating the Self-Association and Colloidal Stability ...New Approaches to Investigating the Self-Association and Colloidal Stability ...
New Approaches to Investigating the Self-Association and Colloidal Stability ...
 
Measuring Comparability of Conformation, Heterogeneity and Aggregation with C...
Measuring Comparability of Conformation, Heterogeneity and Aggregation with C...Measuring Comparability of Conformation, Heterogeneity and Aggregation with C...
Measuring Comparability of Conformation, Heterogeneity and Aggregation with C...
 
Standardized Representations of ELN Reactions for Categorization and Duplicat...
Standardized Representations of ELN Reactions for Categorization and Duplicat...Standardized Representations of ELN Reactions for Categorization and Duplicat...
Standardized Representations of ELN Reactions for Categorization and Duplicat...
 
2015_July GC Synergy from E.coli to Cancer V3
2015_July GC Synergy from E.coli to Cancer V32015_July GC Synergy from E.coli to Cancer V3
2015_July GC Synergy from E.coli to Cancer V3
 
Improving enrichment rates
Improving enrichment ratesImproving enrichment rates
Improving enrichment rates
 
Virtual sreening
Virtual sreeningVirtual sreening
Virtual sreening
 
Reaxys Medicinal Chemistry 2014
Reaxys Medicinal Chemistry 2014Reaxys Medicinal Chemistry 2014
Reaxys Medicinal Chemistry 2014
 
Analyzing Aggregates by Sedimentation Velocity and Light Scattering
Analyzing Aggregates by Sedimentation Velocity and Light ScatteringAnalyzing Aggregates by Sedimentation Velocity and Light Scattering
Analyzing Aggregates by Sedimentation Velocity and Light Scattering
 

Destaque

Hydrogen bonding and molecular design (EuroQSAR 2010)
Hydrogen bonding and molecular design (EuroQSAR 2010)Hydrogen bonding and molecular design (EuroQSAR 2010)
Hydrogen bonding and molecular design (EuroQSAR 2010)Peter Kenny
 
Tales of correlation inflation (2013 CADD GRC)
Tales of correlation inflation (2013 CADD GRC) Tales of correlation inflation (2013 CADD GRC)
Tales of correlation inflation (2013 CADD GRC) Peter Kenny
 
Design of fragment screening libraries (Feb 2010 version)
Design of fragment screening libraries (Feb 2010 version)Design of fragment screening libraries (Feb 2010 version)
Design of fragment screening libraries (Feb 2010 version)Peter Kenny
 
Property-based molecular design: where next? (12-Jun-2015)
Property-based molecular design: where next? (12-Jun-2015)Property-based molecular design: where next? (12-Jun-2015)
Property-based molecular design: where next? (12-Jun-2015)Peter Kenny
 
Perspective of pharmaceutical molecular design
Perspective of pharmaceutical molecular designPerspective of pharmaceutical molecular design
Perspective of pharmaceutical molecular designPeter Kenny
 
A survey of halogens (2008 EuroCUP)
A survey of halogens (2008 EuroCUP)A survey of halogens (2008 EuroCUP)
A survey of halogens (2008 EuroCUP)Peter Kenny
 
I'm a molecule designer... get me out of here!
I'm a molecule designer... get me out of here!I'm a molecule designer... get me out of here!
I'm a molecule designer... get me out of here!Peter Kenny
 
Molecular design: How to and how not to?
Molecular design:  How to and how not to?Molecular design:  How to and how not to?
Molecular design: How to and how not to?Peter Kenny
 
Ligand efficiency: nice concept shame about the metrics
Ligand efficiency: nice concept shame about the metricsLigand efficiency: nice concept shame about the metrics
Ligand efficiency: nice concept shame about the metricsPeter Kenny
 
Some new directions for pharmaceutical molecular design
Some new directions for pharmaceutical molecular designSome new directions for pharmaceutical molecular design
Some new directions for pharmaceutical molecular designPeter Kenny
 
Matrik kegiatan kkg wiyata mandala
Matrik kegiatan kkg wiyata mandalaMatrik kegiatan kkg wiyata mandala
Matrik kegiatan kkg wiyata mandalaYoes Aja
 
An overview of drug discovery
An overview of drug discoveryAn overview of drug discovery
An overview of drug discoveryPeter Kenny
 
partition coefficients in drug discovery
partition coefficients in drug discoverypartition coefficients in drug discovery
partition coefficients in drug discoveryPeter Kenny
 
Lipophilicity in the context of molecular design
Lipophilicity in the context of molecular designLipophilicity in the context of molecular design
Lipophilicity in the context of molecular designPeter Kenny
 
Thermodynamics for medicinal chemistry design
Thermodynamics for medicinal chemistry designThermodynamics for medicinal chemistry design
Thermodynamics for medicinal chemistry designPeter Kenny
 

Destaque (17)

IQSC Oct 2014
IQSC Oct 2014IQSC Oct 2014
IQSC Oct 2014
 
Hydrogen bonding and molecular design (EuroQSAR 2010)
Hydrogen bonding and molecular design (EuroQSAR 2010)Hydrogen bonding and molecular design (EuroQSAR 2010)
Hydrogen bonding and molecular design (EuroQSAR 2010)
 
Tales of correlation inflation (2013 CADD GRC)
Tales of correlation inflation (2013 CADD GRC) Tales of correlation inflation (2013 CADD GRC)
Tales of correlation inflation (2013 CADD GRC)
 
Design of fragment screening libraries (Feb 2010 version)
Design of fragment screening libraries (Feb 2010 version)Design of fragment screening libraries (Feb 2010 version)
Design of fragment screening libraries (Feb 2010 version)
 
Property-based molecular design: where next? (12-Jun-2015)
Property-based molecular design: where next? (12-Jun-2015)Property-based molecular design: where next? (12-Jun-2015)
Property-based molecular design: where next? (12-Jun-2015)
 
Time class VII
Time class VIITime class VII
Time class VII
 
Perspective of pharmaceutical molecular design
Perspective of pharmaceutical molecular designPerspective of pharmaceutical molecular design
Perspective of pharmaceutical molecular design
 
A survey of halogens (2008 EuroCUP)
A survey of halogens (2008 EuroCUP)A survey of halogens (2008 EuroCUP)
A survey of halogens (2008 EuroCUP)
 
I'm a molecule designer... get me out of here!
I'm a molecule designer... get me out of here!I'm a molecule designer... get me out of here!
I'm a molecule designer... get me out of here!
 
Molecular design: How to and how not to?
Molecular design:  How to and how not to?Molecular design:  How to and how not to?
Molecular design: How to and how not to?
 
Ligand efficiency: nice concept shame about the metrics
Ligand efficiency: nice concept shame about the metricsLigand efficiency: nice concept shame about the metrics
Ligand efficiency: nice concept shame about the metrics
 
Some new directions for pharmaceutical molecular design
Some new directions for pharmaceutical molecular designSome new directions for pharmaceutical molecular design
Some new directions for pharmaceutical molecular design
 
Matrik kegiatan kkg wiyata mandala
Matrik kegiatan kkg wiyata mandalaMatrik kegiatan kkg wiyata mandala
Matrik kegiatan kkg wiyata mandala
 
An overview of drug discovery
An overview of drug discoveryAn overview of drug discovery
An overview of drug discovery
 
partition coefficients in drug discovery
partition coefficients in drug discoverypartition coefficients in drug discovery
partition coefficients in drug discovery
 
Lipophilicity in the context of molecular design
Lipophilicity in the context of molecular designLipophilicity in the context of molecular design
Lipophilicity in the context of molecular design
 
Thermodynamics for medicinal chemistry design
Thermodynamics for medicinal chemistry designThermodynamics for medicinal chemistry design
Thermodynamics for medicinal chemistry design
 

Semelhante a Molecular design: One step back and two paths forward

Aspects of pharmaceutical molecular design (Belgrade version)
Aspects of pharmaceutical molecular design (Belgrade version)Aspects of pharmaceutical molecular design (Belgrade version)
Aspects of pharmaceutical molecular design (Belgrade version)Peter Kenny
 
Aspects of pharmaceutical molecular design (Fidelta version)
Aspects of pharmaceutical molecular design (Fidelta version)Aspects of pharmaceutical molecular design (Fidelta version)
Aspects of pharmaceutical molecular design (Fidelta version)Peter Kenny
 
Design of fragment screening libraries (IQPC 2008)
Design of fragment screening libraries (IQPC 2008)Design of fragment screening libraries (IQPC 2008)
Design of fragment screening libraries (IQPC 2008)Peter Kenny
 
Prediction Of Bioactivity From Chemical Structure
Prediction Of Bioactivity From Chemical StructurePrediction Of Bioactivity From Chemical Structure
Prediction Of Bioactivity From Chemical StructureJeremy Besnard
 
Aspects of pharmaceutical molecular design
Aspects of pharmaceutical molecular designAspects of pharmaceutical molecular design
Aspects of pharmaceutical molecular designPeter Kenny
 
Physicochemical Profiling In Drug Research
Physicochemical Profiling In Drug ResearchPhysicochemical Profiling In Drug Research
Physicochemical Profiling In Drug ResearchBrian Bissett
 
htranz_50thCHMS_Poster
htranz_50thCHMS_Posterhtranz_50thCHMS_Poster
htranz_50thCHMS_PosterHolden Ranz
 
Structural Systems Pharmacology
Structural Systems PharmacologyStructural Systems Pharmacology
Structural Systems PharmacologyPhilip Bourne
 
Cadd and molecular modeling for M.Pharm
Cadd and molecular modeling for M.PharmCadd and molecular modeling for M.Pharm
Cadd and molecular modeling for M.PharmShikha Popali
 
ElogPoct: A Tool for Lipophilicity Determination in Drug Discovery
ElogPoct: A Tool for Lipophilicity Determination in Drug DiscoveryElogPoct: A Tool for Lipophilicity Determination in Drug Discovery
ElogPoct: A Tool for Lipophilicity Determination in Drug DiscoveryBrian Bissett
 
Efficient Searching and Similarity of Unmapped Reactions: Application to ELN ...
Efficient Searching and Similarity of Unmapped Reactions: Application to ELN ...Efficient Searching and Similarity of Unmapped Reactions: Application to ELN ...
Efficient Searching and Similarity of Unmapped Reactions: Application to ELN ...NextMove Software
 
Design of compound libraries for fragment screening (Feb 2012 version)
Design of compound libraries for fragment screening (Feb 2012 version)Design of compound libraries for fragment screening (Feb 2012 version)
Design of compound libraries for fragment screening (Feb 2012 version)Peter Kenny
 
Data-analytic sins in property-based molecular design
Data-analytic sins in property-based molecular design Data-analytic sins in property-based molecular design
Data-analytic sins in property-based molecular design Peter Kenny
 
Small Molecules and siRNA: Methods to Explore Bioactivity Data
Small Molecules and siRNA: Methods to Explore Bioactivity DataSmall Molecules and siRNA: Methods to Explore Bioactivity Data
Small Molecules and siRNA: Methods to Explore Bioactivity DataRajarshi Guha
 

Semelhante a Molecular design: One step back and two paths forward (20)

Aspects of pharmaceutical molecular design (Belgrade version)
Aspects of pharmaceutical molecular design (Belgrade version)Aspects of pharmaceutical molecular design (Belgrade version)
Aspects of pharmaceutical molecular design (Belgrade version)
 
Aspects of pharmaceutical molecular design (Fidelta version)
Aspects of pharmaceutical molecular design (Fidelta version)Aspects of pharmaceutical molecular design (Fidelta version)
Aspects of pharmaceutical molecular design (Fidelta version)
 
UCT Oct 2014
UCT Oct 2014UCT Oct 2014
UCT Oct 2014
 
BrazMedChem2014
BrazMedChem2014BrazMedChem2014
BrazMedChem2014
 
Design of fragment screening libraries (IQPC 2008)
Design of fragment screening libraries (IQPC 2008)Design of fragment screening libraries (IQPC 2008)
Design of fragment screening libraries (IQPC 2008)
 
Prediction Of Bioactivity From Chemical Structure
Prediction Of Bioactivity From Chemical StructurePrediction Of Bioactivity From Chemical Structure
Prediction Of Bioactivity From Chemical Structure
 
Aspects of pharmaceutical molecular design
Aspects of pharmaceutical molecular designAspects of pharmaceutical molecular design
Aspects of pharmaceutical molecular design
 
Physicochemical Profiling In Drug Research
Physicochemical Profiling In Drug ResearchPhysicochemical Profiling In Drug Research
Physicochemical Profiling In Drug Research
 
htranz_50thCHMS_Poster
htranz_50thCHMS_Posterhtranz_50thCHMS_Poster
htranz_50thCHMS_Poster
 
NMR Chemical Shift Prediction by Atomic Increment-Based Algorithms
NMR Chemical Shift Prediction by Atomic Increment-Based AlgorithmsNMR Chemical Shift Prediction by Atomic Increment-Based Algorithms
NMR Chemical Shift Prediction by Atomic Increment-Based Algorithms
 
Structural Systems Pharmacology
Structural Systems PharmacologyStructural Systems Pharmacology
Structural Systems Pharmacology
 
Cadd and molecular modeling for M.Pharm
Cadd and molecular modeling for M.PharmCadd and molecular modeling for M.Pharm
Cadd and molecular modeling for M.Pharm
 
ElogPoct: A Tool for Lipophilicity Determination in Drug Discovery
ElogPoct: A Tool for Lipophilicity Determination in Drug DiscoveryElogPoct: A Tool for Lipophilicity Determination in Drug Discovery
ElogPoct: A Tool for Lipophilicity Determination in Drug Discovery
 
Efficient Searching and Similarity of Unmapped Reactions: Application to ELN ...
Efficient Searching and Similarity of Unmapped Reactions: Application to ELN ...Efficient Searching and Similarity of Unmapped Reactions: Application to ELN ...
Efficient Searching and Similarity of Unmapped Reactions: Application to ELN ...
 
Computer aided Drug designing (CADD)
Computer aided Drug designing (CADD)Computer aided Drug designing (CADD)
Computer aided Drug designing (CADD)
 
Design of compound libraries for fragment screening (Feb 2012 version)
Design of compound libraries for fragment screening (Feb 2012 version)Design of compound libraries for fragment screening (Feb 2012 version)
Design of compound libraries for fragment screening (Feb 2012 version)
 
Qsar by hansch analysis
Qsar by hansch analysisQsar by hansch analysis
Qsar by hansch analysis
 
Data-analytic sins in property-based molecular design
Data-analytic sins in property-based molecular design Data-analytic sins in property-based molecular design
Data-analytic sins in property-based molecular design
 
ppt
pptppt
ppt
 
Small Molecules and siRNA: Methods to Explore Bioactivity Data
Small Molecules and siRNA: Methods to Explore Bioactivity DataSmall Molecules and siRNA: Methods to Explore Bioactivity Data
Small Molecules and siRNA: Methods to Explore Bioactivity Data
 

Último

Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 
Russian Call Girls in Andheri Airport Mumbai WhatsApp 9167673311 💞 Full Nigh...
Russian Call Girls in Andheri Airport Mumbai WhatsApp  9167673311 💞 Full Nigh...Russian Call Girls in Andheri Airport Mumbai WhatsApp  9167673311 💞 Full Nigh...
Russian Call Girls in Andheri Airport Mumbai WhatsApp 9167673311 💞 Full Nigh...Pooja Nehwal
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Disha Kariya
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 

Último (20)

Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 
Russian Call Girls in Andheri Airport Mumbai WhatsApp 9167673311 💞 Full Nigh...
Russian Call Girls in Andheri Airport Mumbai WhatsApp  9167673311 💞 Full Nigh...Russian Call Girls in Andheri Airport Mumbai WhatsApp  9167673311 💞 Full Nigh...
Russian Call Girls in Andheri Airport Mumbai WhatsApp 9167673311 💞 Full Nigh...
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 

Molecular design: One step back and two paths forward

  • 1. Molecular Design: One step back and two paths forward Peter W Kenny (pwk.pub.2008@gmail.com)
  • 2. Some things that are hurting Pharma • Having to exploit targets that are less well-linked to human disease • Inability to predict idiosyncratic toxicity • Inability to measure free (unbound) physiological concentrations of drug for remote targets (e.g. intracellular or within blood brain barrier) Dans la merde: http://fbdd-lit.blogspot.com/2011/09/dans-la-merde.html
  • 3. Keep an eye out for creative data analysis
  • 4. Add Normally-distributed noise Data set A Data set B Points plotted at constant increment Equal numbers of points for each value of x Preparation of data sets
  • 5. r2 = 0.99 RMSE = 0.36 Data set A: Fit median value of Y to X An example of this approach to plotting data can be seen in Leeson & Springthorpe, The influence of drug-like concepts on decision-making in medicinal chemistry. Nat. Rev. Drug Discov. 2007, 7, 881-890.
  • 6. Low Medium High Data set B: Use value of X to split into three equally-sized groups and show mean and associated confidence interval for each An example of this approach to analysing data can be seen in: Gleeson, Generation of a Set of Simple, Interpretable ADMET Rules of Thumb. J. Med. Chem. 2008, 51, 817-834.
  • 7. What data set A really looks like Fit to original data N=11000; r2 = 0.09 ; RMSE = 9.95 Fit to transformed data N=11; r2 = 0.99 ; RMSE = 0.36 Percentile plot (see Colclough et al BMC 2008, 16, 6611-6616) 90% 75% 50% 25% 10% Residual plot for fit to original data
  • 8. Fit to original data N=10000; r2 = 0.08 ; RMSE = 10.0) Residual plot for fit to original data Low Medium High What data set B really looks like Mean values of Y and (barely visible) confidence intervals shown with standard deviations x
  • 9. Octanol was the first mistake...
  • 10. Lipophilic & half ionised Hydrophilic Introduction to partition coefficients
  • 11. Polarity N ClogP ≤ 5 Acc ≤ 10; Don ≤5 An alternative view of the Rule of 5
  • 12. Does octanol/water ‘see’ hydrogen bond donors? --0.06 -0.23 -0.24 --1.01 -0.66 Sangster lab database of octanol/water partition coefficients: http://logkow.cisti.nrc.ca/logkow/index.jsp --1.05
  • 13. Octanol/Water Alkane/Water Octanol/water is not the only partitioning system
  • 14. logPoct = 2.1 logPalk = 1.9 DlogP = 0.2 logPoct = 1.5 logPalk = -0.8 DlogP = 2.3 logPoct = 2.5 logPalk = -1.8 DlogP = 4.3 Differences in octanol/water and alkane/water logP values reflect hydrogen bonding between solute and octanol Toulmin et al, J. Med. Chem. 2008, 51, 3720-3730
  • 15. DlogP = 0.5 PSA/ Å2 = 48 Polar Surface Area is not predictive of hydrogen bond strength Toulmin et al, J. Med. Chem. 2008, 51, 3720-3730 DlogP = 4.3 PSA/ Å2 = 22
  • 16. 1.0 1.1 0.8 1.3 1.7 0.8 1.5 Measured values of DlogP Toulmin et al, J. Med. Chem. 2008, 51, 3720-3730 1.6 1.1
  • 17. DlogP (corrected) Vmin/(Hartree/electron) DlogP (corrected) Vmin/(Hartree/electron) N or ether O Carbonyl O Prediction of contribution of acceptors to DlogP Toulmin et al, J. Med. Chem. 2008, 51, 3720-3730 DlogP = DlogP0 x exp(-kVmin)
  • 18. logPoct = 0.89 predicted logPalk = -4.2 PSA/Å2 = 53 logPoct = 1.58 predicted logPalk = -1.4 PSA/Å2 = 65 Lipophilicity/polarity of Morphine & Heroin Toulmin et al, J. Med. Chem. 2008, 51, 3720-3730
  • 19. logPhxdlogPoct log(Cbrain/Cblood) DlogP Prediction of blood/brain partitioning R2 = 0.66 RMSE = 0.54 R2 = 0.82 RMSE = 0.39 R2 = 0.88 RMSE = 0.32 Toulmin et al, J. Med. Chem. 2008, 51, 3720-3730
  • 20. Difficulties in measuring logPalk: Many compounds poorly soluble in alkanes Self-association masks polarity
  • 21. Alkane/water partition coefficients: Where next? General access to logPalk likely to require predictive models for some time Carefully measure logPalk for structurally diverse compounds Solvation models: logPalk easier to measure than ΔG(gaq)
  • 22. Another way to look at SAR
  • 23. (Descriptor-based) QSAR/QSPR: Some questions • How valid is methodology (especially for validation) when distribution of compounds in training/test space is highly non-uniform? • Are models predicting activity or locating neighbours? • Are ‘global’ models ensembles of local models? • How well do the methods handle ‘activity cliffs’? • How should we account for sizes of descriptor pools when comparing models?
  • 24. Measures of Diversity & Coverage • • • • • • • • • • • • • • • 2-Dimensional representation of chemical space is used here to illustrate concepts of diversity and coverage. Stars indicate compounds selected to sample this region of chemical space. In this representation, similar compounds are close together
  • 26. Examples of relationships between structures Tanimoto coefficient (foyfi) for structures is 0.90 Ester is methyl-substituted acid Amides are ‘reversed’
  • 27. Leatherface molecular editor From chain saw to Matched Molecular Pairs c-[A;!R] bnd 1 2 c-Br cul 2 hyd 1 1 [nX2]1c([OH])cccc1 hyd 1 1 hyd 3 -1 bnd 2 3 2 Kenny & Sadowski Structure modification in chemical databases, Methods and Principles in Medicinal Chemistry (Chemoinformatics in Drug Discovery 2005, 23, 271-285.
  • 28. Glycogen Phosphorylase inhibitors: Series comparison DpIC50 DlogFu DlogS 0.38 (0.06) -0.30 (0.06) -0.29 (0.13) DpIC50 DlogFu DlogS 0.21 (0.06) 0.13 (0.04) 0.20 (0.09) DpIC50 DlogFu DlogS 0.29 (0.07) -0.42 (0.08) -0.62 (0.13) Standard errors in mean values shown in parenthesis; see Birch et al, BMCL 2009, 19, 850-853
  • 29. Effect of bioisosteric replacement on plasma protein binding ? Date of Analysis N DlogFu SE SD %increase 2003 7 -0.64 0.09 0.23 0 2008 12 -0.60 0.06 0.20 0 Mining PPB database for carboxylate/tetrazole pairs suggested that bioisosteric replacement would lead to decrease in Fu so tetrazoles not synthesised. Birch et al, BMCL 2009, 19, 850-853
  • 30. Amide N DlogS SE SD %Increase Acyclic (aliphatic amine) 109 0.59 0.07 0.71 76 Cyclic 9 0.18 0.15 0.47 44 Benzanilides 9 1.49 0.25 0.76 100 Effect of amide N-methylation on aqueous solubility is dependent on substructural context Birch et al, BMCL 2009, 19, 850-853
  • 31. Relationships between structures Discover new bioisosteres Prediction of activity & properties Recognise extreme data Direct prediction (e.g. look up substituent effects) Indirect prediction (e.g. apply correction to existing model) Bad measurement or interesting effect?
  • 32. Conclusions • Data can be massaged and correlations can be enhanced but it won’t extract us from ‘la merde’ • There is life beyond octanol/water if we choose to look for it • Even molecules can have meaningful relationships
  • 33. Selected references • Seiler (1974) Interconversion of lipophilicities from hydrocarbon/water systems into the octanol/water system. Eur. J. Med. Chem. 9, 473–479. • Toulmin, Wood & Kenny (2008) Toward Prediction of Alkane/Water Partition Coefficients. J. Med. Chem. 51, 3720-3730. http://dx.doi.org/10.1021/jm701549s • Kenny & Sadowskii (2005) Structure modification in chemical databases. Methods and Principles in Medicinal Chemistry 23(Chemoinformatics in Drug Discovery), 271-285 http://dx.doi.org/10.1002/3527603743.ch11 • Leach et al (2006) Matched Molecular Pairs as a Guide in the Optimization of Pharmaceutical Properties; a Study of Aqueous Solubility, Plasma Protein Binding and Oral Exposure,. J. Med. Chem. 49, 6672-6682. http://dx.doi.org/10.1021/jm0605233 • Birch et al (2009) Matched molecular pair analysis of activity and properties of glycogen phosphorylase inhibitors. Bioorg. Med. Chem. Lett. 19, 850-853. http://dx.doi.org/10.1016/j.bmcl.2008.12.003 • Wassermann, Wawer & Bajorath (2010) Activity Landscape Representations for Structure−Activity Relationship Analysis. J. Med. Chem. 53, 8209-8223. http://dx.doi.org/10.1021/jm100933w Alkane/water partition coefficents Relationships between structures